Back to Search Start Over

Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment.

Authors :
Carissimi F
Barbaglia MN
Salmi L
Ciulli C
Roccamatisi L
Cordaro G
Mallela VR
Minisini R
Leone BE
Donadon M
Torzilli G
Pirisi M
Romano F
Famularo S
Source :
World journal of gastrointestinal surgery [World J Gastrointest Surg] 2021 Sep 27; Vol. 13 (9), pp. 967-978.
Publication Year :
2021

Abstract

The treatment for hepatocellular carcinoma (HCC) relies on liver resection, which is, however, burdened by a high rate of recurrence after surgery, up to 60% at 5 years. No pre-operative tools are currently available to assess the recurrence risk tailored to every single patient. Recently liquid biopsy has shown interesting results in diagnosis, prognosis and treatment allocation strategies in other types of cancers, since its ability to identify circulating tumor cells (CTCs) derived from the primary tumor. Those cells were advocated to be responsible for the majority of cases of recurrence and cancer-related deaths for HCC. In fact, after being modified by the epithelial-mesenchymal transition, CTCs circulate as "seeds" in peripheral blood, then reach the target organ as dormant cells which could be subsequently "awakened" and activated, and then initiate metastasis. Their presence may justify the disagreement registered in terms of efficacy of anatomic vs non-anatomic resections, particularly in the case of microvascular invasion, which has been recently pointed as a histological sign of the spread of those cells. Thus, their presence, also in the early stages, may justify the recurrence event also in the contest of liver transplant. Understanding the mechanism behind the tumor progression may allow improving the treatment selection according to the biological patient-based characteristics. Moreover, it may drive the development of novel biological tailored tests which could address a specific patient to neoadjuvant or adjuvant strategies, and in perspective, it could also become a new method to allocate organs for transplantation, according to the risk of relapse after liver transplant. The present paper will describe the most recent evidence on the role of CTCs in determining the relapse of HCC, highlighting their potential clinical implication as novel tumor behavior biomarkers able to influence the surgical choice.<br />Competing Interests: Conflict-of-interest statement: The authors declare that they have no conflict of interest.<br /> (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.)

Details

Language :
English
ISSN :
1948-9366
Volume :
13
Issue :
9
Database :
MEDLINE
Journal :
World journal of gastrointestinal surgery
Publication Type :
Academic Journal
Accession number :
34621473
Full Text :
https://doi.org/10.4240/wjgs.v13.i9.967